L-NAME prevents anxiety-like and depression-like behavior in rats exposed to restraint stress
Stressful life events contribute to the development of many neuropsychiatric disorders including depression and anxiety. Animal studies based on the relationship of stress and depression or anxiety are scarce and controversial. Moreover, neither the neurobiological basis of anxiety and depression no...
Gespeichert in:
Veröffentlicht in: | Methods and Findings in Experimental and Clinical Pharmacology 2006-03, Vol.28 (2), p.95-99 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 99 |
---|---|
container_issue | 2 |
container_start_page | 95 |
container_title | Methods and Findings in Experimental and Clinical Pharmacology |
container_volume | 28 |
creator | SEVGI, S ÖZEK, M EROGLU, L |
description | Stressful life events contribute to the development of many neuropsychiatric disorders including depression and anxiety. Animal studies based on the relationship of stress and depression or anxiety are scarce and controversial. Moreover, neither the neurobiological basis of anxiety and depression nor the mechanisms responsible for neurochemical regulation by stressful stimuli are well understood. This study was designed to investigate the possible contribution of both acute (2 h) and chronic (2 h X 15 d) restraint stress in the generation of anxiety and depression, and also to find out whether nitric oxide (NO) has a modulatory role in these behavioral reactions. Elevated plus-maze and forced swimming test (FST) were chosen for assessment of anxiety and depression, respectively, and N(G)-nitro L-arginine methyl ester (L-NAME, 10 mg/kg), a NO synthase (NOS) inhibitor, and L-arginine (50 mg/kg), a NO precursor, were used to evaluate the role of nitrergic system in restraint exposed rats. The results showed that acute and chronic stress caused depression-like and anxiety-like behaviors in rats and the acute inhibition of NOS by L-NAME prevented these acute and chronic stress-induced anxiogenesis and depression. These data lead to the conclusion that stress and NO seem to be involved in the generation of anxiety and depression. |
doi_str_mv | 10.1358/mf.2006.28.2.977840 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67897486</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67897486</sourcerecordid><originalsourceid>FETCH-LOGICAL-c333t-b93e6f485a850611eca0561cc9d0c31771ab7c57f00d893876f5ba6104bd7d5a3</originalsourceid><addsrcrecordid>eNpFkElPwzAQhX0A0VL4BUgoF7gl2HG85FhVZZEKXOCILMeLMGTDTqv23-MqkXp6mpnvPY0eADcIZggT_tDYLIeQZjnP8qxkjBfwDMwhZmUKMSEzcBnCD4Q5IphcgBmiFFOGyjn42qRvy9d10nuzM-0QEtnunRkOae1-TRx0ok28heC6dtxV5lvuXOcT1yZeRofZ910wOhm6JIKDl64dkqjRdAXOrayDuZ50AT4f1x-r53Tz_vSyWm5ShTEe0qrEhtqCE8kJpAgZJSGhSKlSQ4URY0hWTBFmIdS8xJxRSypJESwqzTSReAHux9zed3_b-IRoXFCmrmVrum0QlPGSFZxGEI-g8l0I3ljRe9dIfxAIimOTorHi2KTIucjF2GR03U7x26ox-uSZaozA3QTIoGRtvWyVCyeOMZwjhPE_tWR-1Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67897486</pqid></control><display><type>article</type><title>L-NAME prevents anxiety-like and depression-like behavior in rats exposed to restraint stress</title><source>MEDLINE</source><source>Portico (Triggered Content) Journals</source><creator>SEVGI, S ; ÖZEK, M ; EROGLU, L</creator><creatorcontrib>SEVGI, S ; ÖZEK, M ; EROGLU, L</creatorcontrib><description>Stressful life events contribute to the development of many neuropsychiatric disorders including depression and anxiety. Animal studies based on the relationship of stress and depression or anxiety are scarce and controversial. Moreover, neither the neurobiological basis of anxiety and depression nor the mechanisms responsible for neurochemical regulation by stressful stimuli are well understood. This study was designed to investigate the possible contribution of both acute (2 h) and chronic (2 h X 15 d) restraint stress in the generation of anxiety and depression, and also to find out whether nitric oxide (NO) has a modulatory role in these behavioral reactions. Elevated plus-maze and forced swimming test (FST) were chosen for assessment of anxiety and depression, respectively, and N(G)-nitro L-arginine methyl ester (L-NAME, 10 mg/kg), a NO synthase (NOS) inhibitor, and L-arginine (50 mg/kg), a NO precursor, were used to evaluate the role of nitrergic system in restraint exposed rats. The results showed that acute and chronic stress caused depression-like and anxiety-like behaviors in rats and the acute inhibition of NOS by L-NAME prevented these acute and chronic stress-induced anxiogenesis and depression. These data lead to the conclusion that stress and NO seem to be involved in the generation of anxiety and depression.</description><identifier>ISSN: 0379-0355</identifier><identifier>ISSN: 2013-0155</identifier><identifier>DOI: 10.1358/mf.2006.28.2.977840</identifier><identifier>PMID: 16636719</identifier><language>eng</language><publisher>Barcelona: Prous</publisher><subject>Acute Disease ; Animals ; Anxiety - etiology ; Anxiety - prevention & control ; Arginine - pharmacology ; Biological and medical sciences ; Chronic Disease ; Depression - etiology ; Depression - prevention & control ; Disease Models, Animal ; Dose-Response Relationship, Drug ; General pharmacology ; Male ; Medical sciences ; NG-Nitroarginine Methyl Ester - administration & dosage ; NG-Nitroarginine Methyl Ester - pharmacology ; Nitric Oxide - biosynthesis ; Nitric Oxide Synthase - antagonists & inhibitors ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Rats ; Rats, Wistar ; Restraint, Physical ; Stress, Psychological - complications</subject><ispartof>Methods and Findings in Experimental and Clinical Pharmacology, 2006-03, Vol.28 (2), p.95-99</ispartof><rights>2006 INIST-CNRS</rights><rights>(c) 2006 Prous Science. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c333t-b93e6f485a850611eca0561cc9d0c31771ab7c57f00d893876f5ba6104bd7d5a3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17732113$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16636719$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SEVGI, S</creatorcontrib><creatorcontrib>ÖZEK, M</creatorcontrib><creatorcontrib>EROGLU, L</creatorcontrib><title>L-NAME prevents anxiety-like and depression-like behavior in rats exposed to restraint stress</title><title>Methods and Findings in Experimental and Clinical Pharmacology</title><addtitle>Methods Find Exp Clin Pharmacol</addtitle><description>Stressful life events contribute to the development of many neuropsychiatric disorders including depression and anxiety. Animal studies based on the relationship of stress and depression or anxiety are scarce and controversial. Moreover, neither the neurobiological basis of anxiety and depression nor the mechanisms responsible for neurochemical regulation by stressful stimuli are well understood. This study was designed to investigate the possible contribution of both acute (2 h) and chronic (2 h X 15 d) restraint stress in the generation of anxiety and depression, and also to find out whether nitric oxide (NO) has a modulatory role in these behavioral reactions. Elevated plus-maze and forced swimming test (FST) were chosen for assessment of anxiety and depression, respectively, and N(G)-nitro L-arginine methyl ester (L-NAME, 10 mg/kg), a NO synthase (NOS) inhibitor, and L-arginine (50 mg/kg), a NO precursor, were used to evaluate the role of nitrergic system in restraint exposed rats. The results showed that acute and chronic stress caused depression-like and anxiety-like behaviors in rats and the acute inhibition of NOS by L-NAME prevented these acute and chronic stress-induced anxiogenesis and depression. These data lead to the conclusion that stress and NO seem to be involved in the generation of anxiety and depression.</description><subject>Acute Disease</subject><subject>Animals</subject><subject>Anxiety - etiology</subject><subject>Anxiety - prevention & control</subject><subject>Arginine - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Chronic Disease</subject><subject>Depression - etiology</subject><subject>Depression - prevention & control</subject><subject>Disease Models, Animal</subject><subject>Dose-Response Relationship, Drug</subject><subject>General pharmacology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>NG-Nitroarginine Methyl Ester - administration & dosage</subject><subject>NG-Nitroarginine Methyl Ester - pharmacology</subject><subject>Nitric Oxide - biosynthesis</subject><subject>Nitric Oxide Synthase - antagonists & inhibitors</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Restraint, Physical</subject><subject>Stress, Psychological - complications</subject><issn>0379-0355</issn><issn>2013-0155</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkElPwzAQhX0A0VL4BUgoF7gl2HG85FhVZZEKXOCILMeLMGTDTqv23-MqkXp6mpnvPY0eADcIZggT_tDYLIeQZjnP8qxkjBfwDMwhZmUKMSEzcBnCD4Q5IphcgBmiFFOGyjn42qRvy9d10nuzM-0QEtnunRkOae1-TRx0ok28heC6dtxV5lvuXOcT1yZeRofZ910wOhm6JIKDl64dkqjRdAXOrayDuZ50AT4f1x-r53Tz_vSyWm5ShTEe0qrEhtqCE8kJpAgZJSGhSKlSQ4URY0hWTBFmIdS8xJxRSypJESwqzTSReAHux9zed3_b-IRoXFCmrmVrum0QlPGSFZxGEI-g8l0I3ljRe9dIfxAIimOTorHi2KTIucjF2GR03U7x26ox-uSZaozA3QTIoGRtvWyVCyeOMZwjhPE_tWR-1Q</recordid><startdate>20060301</startdate><enddate>20060301</enddate><creator>SEVGI, S</creator><creator>ÖZEK, M</creator><creator>EROGLU, L</creator><general>Prous</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060301</creationdate><title>L-NAME prevents anxiety-like and depression-like behavior in rats exposed to restraint stress</title><author>SEVGI, S ; ÖZEK, M ; EROGLU, L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c333t-b93e6f485a850611eca0561cc9d0c31771ab7c57f00d893876f5ba6104bd7d5a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Acute Disease</topic><topic>Animals</topic><topic>Anxiety - etiology</topic><topic>Anxiety - prevention & control</topic><topic>Arginine - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Chronic Disease</topic><topic>Depression - etiology</topic><topic>Depression - prevention & control</topic><topic>Disease Models, Animal</topic><topic>Dose-Response Relationship, Drug</topic><topic>General pharmacology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>NG-Nitroarginine Methyl Ester - administration & dosage</topic><topic>NG-Nitroarginine Methyl Ester - pharmacology</topic><topic>Nitric Oxide - biosynthesis</topic><topic>Nitric Oxide Synthase - antagonists & inhibitors</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Restraint, Physical</topic><topic>Stress, Psychological - complications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SEVGI, S</creatorcontrib><creatorcontrib>ÖZEK, M</creatorcontrib><creatorcontrib>EROGLU, L</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Methods and Findings in Experimental and Clinical Pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SEVGI, S</au><au>ÖZEK, M</au><au>EROGLU, L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>L-NAME prevents anxiety-like and depression-like behavior in rats exposed to restraint stress</atitle><jtitle>Methods and Findings in Experimental and Clinical Pharmacology</jtitle><addtitle>Methods Find Exp Clin Pharmacol</addtitle><date>2006-03-01</date><risdate>2006</risdate><volume>28</volume><issue>2</issue><spage>95</spage><epage>99</epage><pages>95-99</pages><issn>0379-0355</issn><issn>2013-0155</issn><abstract>Stressful life events contribute to the development of many neuropsychiatric disorders including depression and anxiety. Animal studies based on the relationship of stress and depression or anxiety are scarce and controversial. Moreover, neither the neurobiological basis of anxiety and depression nor the mechanisms responsible for neurochemical regulation by stressful stimuli are well understood. This study was designed to investigate the possible contribution of both acute (2 h) and chronic (2 h X 15 d) restraint stress in the generation of anxiety and depression, and also to find out whether nitric oxide (NO) has a modulatory role in these behavioral reactions. Elevated plus-maze and forced swimming test (FST) were chosen for assessment of anxiety and depression, respectively, and N(G)-nitro L-arginine methyl ester (L-NAME, 10 mg/kg), a NO synthase (NOS) inhibitor, and L-arginine (50 mg/kg), a NO precursor, were used to evaluate the role of nitrergic system in restraint exposed rats. The results showed that acute and chronic stress caused depression-like and anxiety-like behaviors in rats and the acute inhibition of NOS by L-NAME prevented these acute and chronic stress-induced anxiogenesis and depression. These data lead to the conclusion that stress and NO seem to be involved in the generation of anxiety and depression.</abstract><cop>Barcelona</cop><pub>Prous</pub><pmid>16636719</pmid><doi>10.1358/mf.2006.28.2.977840</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0379-0355 |
ispartof | Methods and Findings in Experimental and Clinical Pharmacology, 2006-03, Vol.28 (2), p.95-99 |
issn | 0379-0355 2013-0155 |
language | eng |
recordid | cdi_proquest_miscellaneous_67897486 |
source | MEDLINE; Portico (Triggered Content) Journals |
subjects | Acute Disease Animals Anxiety - etiology Anxiety - prevention & control Arginine - pharmacology Biological and medical sciences Chronic Disease Depression - etiology Depression - prevention & control Disease Models, Animal Dose-Response Relationship, Drug General pharmacology Male Medical sciences NG-Nitroarginine Methyl Ester - administration & dosage NG-Nitroarginine Methyl Ester - pharmacology Nitric Oxide - biosynthesis Nitric Oxide Synthase - antagonists & inhibitors Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Rats Rats, Wistar Restraint, Physical Stress, Psychological - complications |
title | L-NAME prevents anxiety-like and depression-like behavior in rats exposed to restraint stress |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T18%3A11%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=L-NAME%20prevents%20anxiety-like%20and%20depression-like%20behavior%20in%20rats%20exposed%20to%20restraint%20stress&rft.jtitle=Methods%20and%20Findings%20in%20Experimental%20and%20Clinical%20Pharmacology&rft.au=SEVGI,%20S&rft.date=2006-03-01&rft.volume=28&rft.issue=2&rft.spage=95&rft.epage=99&rft.pages=95-99&rft.issn=0379-0355&rft_id=info:doi/10.1358/mf.2006.28.2.977840&rft_dat=%3Cproquest_cross%3E67897486%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67897486&rft_id=info:pmid/16636719&rfr_iscdi=true |